Affiliation:
1. Federal Research Center “Krasnoyarsk Research Center” of the Siberian Branch of the Russian Academy of Sciences, a separate subdivision of Research Institute for Medical Problems in the North (NII MPS)
2. Remishevskaya Khakas Republican Hospital
Abstract
The article analyzes the prevalence and principles in treatment of Barrett’s esophagus. The prevalence of Barrett’s esophagus varies widely from region to region of the world and has ethnic differences. The use of endoscopic methods and the histological examination of the biopsies of esophageal mucosa are of utmost importance in the diagnosis of this pathology. The prevention of esophageal cancer is the main task in managing patients with Barrett’s esophagus. The length of the Barrett’s esophagus segment, the presence and extent of dysplasia is of the greatest importance to select tactics for managing patients. Endoscopic methods are widely used for the eradication of metaplasia sites, among which the radiofrequency ablation is the most effective one. Prolonged treatment with proton pump inhibitors is safe and reduces the risk of transformation of Barrett’s esophagus into adenocarcinoma of the esophagus. There is evidence that small doses of aspirin, nonsteroidal anti-inflammatory drugs, statins and ursodeoxycholic acid have the preventive effect on the development of esophageal cancer. However, the possibilities of using these drugs for this purpose are still limited. Anti-reflux surgery still holds relevance, but at the same time, it has no advantages over the drug therapy for the prevention of esophageal cancer.
Reference28 articles.
1. Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. Am J Gastroenterol, 2016, 111(1): 30-50.
2. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut, 2014, 63(1): 7-42.
3. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol, 2008, 103(3): 788-797.
4. Tsukanov VV, Onuchina EV, Vasyutin AV, Butorin NN, Amelchugova OS. Clinical aspects of gastroesophageal reflux disease in the elderly: the 5-year prospective study results. Terapevtichesky Arkhiv, 2014, 86 (2): 23-26.
5. Tsukanov VV, Amelchugova OS, Kasparov EV, Butorin NN, Vasyutin AV, Tonkikh YuL, Tretyakova OV. The role of Helicobacter pylori eradication in the prevention of gastric cancer. Terapevtichesky Arkhiv, 2014, 86 (8): 124-127.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献